These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3282464)

  • 1. Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for chronic beryllium disease.
    Rossman MD; Kern JA; Elias JA; Cullen MR; Epstein PE; Preuss OP; Markham TN; Daniele RP
    Ann Intern Med; 1988 May; 108(5):687-93. PubMed ID: 3282464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcoidosis and chronic beryllium disease: similarities and differences.
    Mayer AS; Hamzeh N; Maier LA
    Semin Respir Crit Care Med; 2014 Jun; 35(3):316-29. PubMed ID: 25007084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferative response to beryllium.
    Newman LS; Kreiss K
    Am Rev Respir Dis; 1992 May; 145(5):1212-4. PubMed ID: 1586067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood cell proliferation response to beryllium: analysis by receiver-operating characteristics.
    Stokes RF; Rossman MD
    J Occup Med; 1991 Jan; 33(1):23-8. PubMed ID: 1995798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is chronic beryllium disease sarcoidosis of known etiology?
    Rossman MD; Kreider ME
    Sarcoidosis Vasc Diffuse Lung Dis; 2003 Jun; 20(2):104-9. PubMed ID: 12870719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history.
    Newman LS; Kreiss K; King TE; Seay S; Campbell PA
    Am Rev Respir Dis; 1989 Jun; 139(6):1479-86. PubMed ID: 2729754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The beryllium bronchoalveolar lavage lymphocyte proliferation test: indicator of beryllium sensitization, inflammation or both?
    Heldt GH; Deubner DC
    Inhal Toxicol; 2015; 27(5):262-71. PubMed ID: 25942054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compartmentalized immune response reflects clinical severity of beryllium disease.
    Newman LS; Bobka C; Schumacher B; Daniloff E; Zhen B; Mroz MM; King TE
    Am J Respir Crit Care Med; 1994 Jul; 150(1):135-42. PubMed ID: 8025739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic beryllium disease: diagnosis and management.
    Rossman MD
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):945-7. PubMed ID: 8933039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine production by bronchoalveolar lavage cells in chronic beryllium disease.
    Tinkle SS; Schwitters PW; Newman LS
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):969-71. PubMed ID: 8933043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease.
    Mroz MM; Kreiss K; Lezotte DC; Campbell PA; Newman LS
    J Allergy Clin Immunol; 1991 Jul; 88(1):54-60. PubMed ID: 2071785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beryllium induces IL-2 and IFN-gamma in berylliosis.
    Tinkle SS; Kittle LA; Schumacher BA; Newman LS
    J Immunol; 1997 Jan; 158(1):518-26. PubMed ID: 8977230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic beryllium disease in a precious metal refinery. Clinical epidemiologic and immunologic evidence for continuing risk from exposure to low level beryllium fume.
    Cullen MR; Kominsky JR; Rossman MD; Cherniack MG; Rankin JA; Balmes JR; Kern JA; Daniele RP; Palmer L; Naegel GP
    Am Rev Respir Dis; 1987 Jan; 135(1):201-8. PubMed ID: 3492158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease.
    Sawyer RT; Day BJ; Fadok VA; Chiarappa-Zucca M; Maier LA; Fontenot AP; Silveira L; Newman LS
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):470-7. PubMed ID: 15256386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchoalveolar lavage in a patient with chronic berylliosis: evidence for hypersensitivity pneumonitis.
    Epstein PE; Dauber JH; Rossman MD; Daniele RP
    Ann Intern Med; 1982 Aug; 97(2):213-6. PubMed ID: 7103279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beryllium stimulates release of T helper 1 cytokines interleukin-2 and interferon gamma from BAL cells in chronic beryllium disease.
    Tinkle S; Kittle L; Schwitters PW; Addison JR; Newman LS
    Chest; 1996 Mar; 109(3 Suppl):5S-6S. PubMed ID: 8598153
    [No Abstract]   [Full Text] [Related]  

  • 17. Beryllium-stimulated neopterin as a diagnostic adjunct in chronic beryllium disease.
    Maier LA; Kittle LA; Mroz MM; Newman LS
    Am J Ind Med; 2003 Jun; 43(6):592-601. PubMed ID: 12768609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [It's difficult to differentiate between sarcoidosis and berylliosis!].
    Grunewald J; Eklund A
    Lakartidningen; 2000 Dec; 97(50):5915-8. PubMed ID: 11188534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF polymorphism and bronchoalveolar lavage cell TNF-alpha levels in chronic beryllium disease and beryllium sensitization.
    Sato H; Silveira L; Fingerlin T; Dockstader K; Gillespie M; Lagan AL; Lympany P; Sawyer RT; du Bois RM; Welsh KI; Maier LA
    J Allergy Clin Immunol; 2007 Mar; 119(3):687-96. PubMed ID: 17208287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alveolar macrophages from patients with beryllium disease and sarcoidosis express increased levels of mRNA for tumor necrosis factor-alpha and interleukin-6 but not interleukin-1 beta.
    Bost TW; Riches DW; Schumacher B; Carré PC; Khan TZ; Martinez JA; Newman LS
    Am J Respir Cell Mol Biol; 1994 May; 10(5):506-13. PubMed ID: 8179912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.